Sign in
4

Changes in Ownership

CNS Pharmaceuticals, Inc. Filed Acc 0001683168-23-002096

Options or other derivatives

  • Chief Executive Officer acquired 16,467 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Climaco John M · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-29 Grant or award : show line 1 in the form Restricted Stock Units +16,467 61,451 D
Loading xslF345X04/ownership.xml…